+654.5%
MRNA vs ALB
+57.6%
+596.9%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | ALB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.6% | +2.6% | -6.2% | -4.3% |
| 7D | -9.0% | -4.4% | -4.6% | -8.0% |
| 30D | +137.2% | -1.2% | +138.3% | +137.5% |
| 3M | +194.8% | -13.3% | +208.1% | +204.6% |
| 6M | +167.2% | -19.8% | +187.0% | +179.0% |
| YTD | +375.9% | -7.9% | +383.8% | +378.6% |
| 1Y | +465.2% | +60.2% | +405.0% | +386.5% |
| 3Y | +30.4% | -26.4% | +56.8% | +27.3% |
| 5Y | -66.8% | -42.5% | -24.3% | -66.9% |
| All | +654.5% | +57.6% | +596.9% | +567.2% |
Cumulative growth
Daily Returns
Daily percentage return beside ALB.
Daily Out/Under-Performance
Portfolio return minus ALB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded ALB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling